According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that China Resources Pharmaceutical Group, a subsidiary of the company, achieved total operating revenue of 1,643 billion yuan for the six months ended June 30, 2026, a year-on-year decrease of 50.97%; the net loss attributable to shareholders of listed companies was 364 million yuan, while net profit of 198 million yuan was achieved during the same period last year; a basic loss of 0.48 yuan per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.